However, a recent meta-analysis reported improved spontaneous pregnancy rates in breast cancer patients treated with GnRH agonists, though these findings were only applicable to hormone receptor-negative women (Li et al. 2022). This evidence concerns the gene GNRH1 and breast cancer.